PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: InnovaSystems, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

InnovaSystems Launches A New Actuator for Testing of Nasal Spray Products - InnovaSystems introduces the newest member of it's actuator family; the NSP Universal Actuator - InnovaSystems.com
InnovaSystems Launches A New Actuator for Testing of Nasal Spray Products

 

NewswireToday - /newswire/ - Moorestown, NJ, United States, 2010/05/27 - InnovaSystems introduces the newest member of it's actuator family; the NSP Universal Actuator - InnovaSystems.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The NSP Universal Actuator (NSP UA) was well received during its debut at RDD 2010. It’s burgundy, steel and black motif caught the eye of visitors but the innovative color scheme isn’t all that makes the NSP UA stand out.

The NSP UA is the newest member of InnovaSystems’ family of NSP actuators. Our actuators automate the routine actuation of Nasal Spray Products and Metered Dose Inhaler Products for performing FDA Recommended Tests.

Historically, actuators offered only a single mode of operation. For example; InnovaSystems’ Mighty Runt Actuation Station actuates the product by applying a controlled force while the NSP Velocity Actuator (NSP VA) actuates the product at a specified velocity. The new NSP UA uses Linear Motor Technology which enables user selectable Velocity or Force mode of actuation, while providing superior accuracy and reliability.

The NSP UA is easy-to-use; just place the bottle on the platform, select a stored product and start. To aide commissioning, actuation parameters from InnovaSystems’ Mighty Runt and NSP VA Actuators are easily transferred to the NSP UA.

The NSP UA monitors the actual velocity or force and distance of each actuation. Actuations are highly reproducible and monitored with user definable Pass / Fail criteria. The NSP UA provides graphical views of Live or historical actuation data. Force / Travel and Energy / Travel graphs are provided. Users may isolate single actuation profiles and compare them against other actuations. Data may also be output to a Comma Separated Values (CSV) file or to a Portable Document File (PDF).

The NSP UA supports 21CFR Part 11 Compliance and simplifies validation with IQ/OQ documentation.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: InnovaSystems, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


InnovaSystems Launches A New Actuator for Testing of Nasal Spray Products

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Richard Sellers - InnovaSystems.com 
856-722-0410 rsellers[.]innovasystems.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any InnovaSystems, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From InnovaSystems, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)